HIMS
Hims & Hers Health, Inc.
Latest close $31.99 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 7 parsed filing(s) · 4 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 observed Jul 31, 2026 filed · 31d Initial Schedule 13G | Initial Schedule 13G | 11.2M | 12.00% | $34.67 | $27.77 | $31.99 |
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 28, 2026 filed · 28d Schedule 13G amendment | Reported reduction | 26.5M -3.1M | 12.00% -2.20 pts | $34.67 | $29.32 | $31.99 |
| JPMorgan Chase / Asset Management CIK0000019617 | Feb 27, 2026 observed Mar 5, 2026 filed · 6d Schedule 13G amendment | Earliest Schedule 13G amendment found | 3.9M | 12.00% | $15.88 | $31.99 |